MEQUON, Wis.--(BUSINESS WIRE)--Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that it has achieved 27,000 implantations of its Endoskeleton® interbody fusion devices since its inception – an increase of 25% from 2013 – and has achieved a $26 million annualized sales revenue run-rate. Collectively, these achievements demonstrate significant growth over the past year and continue to reflect the ongoing ra
| < Prev | Next > |
|---|
